Drugs / Dexamethasone Ophthalmic
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05387941 | Jun 2022 → Mar 2026 | retinopathy of prematurity | Region Skane | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dexamethasone Ophthalmic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05387941 ↗ |
| Modality | Small molecule | “steroid eye drops” NCT05387941 ↗ |
| Route | Other | “one drop daily in each eye” NCT05387941 ↗ |